Hello! I’m Dr. Lisa Larkin founder and CEO of Ms.Medicine. Here at Ms.Medicine, we believe that patient’s deserve better. Our goal as an organization is to raise the standard of care, especially for women and to do so we must advocate, educate, and innovate. With enthusiasm and commitment to providing outstanding primary care, I firmly believe that our practices must continually educate themselves on cutting edge technology and changes in evidence-based practices.

As not only a physician, but also a cancer survivor, I believe that knowledge is power, and I’d like to discuss the importance of the Galleri Multi-Cancer Early Detection Test our practices are now offering. Cancer is the second leading causes of death in the United States and despite the available preventative screening tools, a vast majority of cancers are found too late. Early detection not only improves survival rates but also increases treatment options.

The innovation behind this test is amazing to say the least. Finally, a simple blood test that provides significant insight into your risk related to more than 50 different types of cancer. While the Galleri Test is not for everyone, nor is it intended to replace other cancer screenings, it gives providers additional resources to assess your risk and helps you to be proactive about your health. Let us help provide you and your loved ones with peace of mind by discussing if the Galleri Multi-Cancer Early Detection Test is appropriate for you.

Whether you are a member of a Ms.Medicine practice or simply a visitor interested in knowing their risks, we welcome you. We hope that you will join us on the journey toward better healthcare because you deserve better!